BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 12734778)

  • 1. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
    Ram PA; Waxman DJ
    J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the growth hormone receptor with cytokine-induced Src homology domain 2 protein in rat adipocytes.
    Du L; Frick GP; Tai LR; Yoshimura A; Goodman HM
    Endocrinology; 2003 Mar; 144(3):868-76. PubMed ID: 12586763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo.
    Mao Y; Ling PR; Fitzgibbons TP; McCowen KC; Frick GP; Bistrian BR; Smith RJ
    Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
    Ram PA; Waxman DJ
    J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
    Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
    Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
    Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
    Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
    Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
    Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes.
    Eriksson H; Ridderstråle M; Tornqvist H
    Endocrinology; 1995 Nov; 136(11):5093-101. PubMed ID: 7588246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
    Story DJ; Stephens JM
    Obesity (Silver Spring); 2006 Aug; 14(8):1303-11. PubMed ID: 16988072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
    Ueki K; Kondo T; Kahn CR
    Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
    Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
    Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes.
    Fasshauer M; Kralisch S; Klier M; Lossner U; Bluher M; Klein J; Paschke R
    J Endocrinol; 2004 Apr; 181(1):129-38. PubMed ID: 15072573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.